Video

Unmet Needs, Future Directions, and Clinical Pearls in mCRPC

Author(s):

Stephen J. Freedland, MD

Dr. Freedland closes his discussion by highlighting remaining unmet needs in mCRPC treatment and providing some clinical pearls for community oncologists treating patients with the disease.

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected

      Newsletter

      Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.

      Subscribe Now!
      Related Videos
      Manuj Agarwal, MD, on patient selection for prostate brachytherapy
      Manuj Agarwal, MD, on patient selection for prostate brachytherapy
      DASH flexitarian mediterranean diet to stop hypertension, low blood pressure | Image Credit: © aamulya - stock.adobe.com
      Stephen J. Freedland, MD, highlights the role of diet in prostate cancer management
      Conceptual image for prostate cancer treatment, 3D illustration showing destruction of a tumor inside prostate gland | Image Credit: © Dr_Microbe - stock.adobe.com
      Shared decision-making: Clarifying roles in prostate cancer care
      Related Content
      Study highlights gaps in PCP knowledge on PSA testing for Black men
      September 23rd 2025

      Study highlights gaps in PCP knowledge on PSA testing for Black men

      Hannah Clarke
      Pearls & Perspectives: Optimizing Outcomes in Prostate Cancer, with Mark L. Gonzalgo, MD, PhD
      September 23rd 2025

      Pearls & Perspectives: Optimizing Outcomes in Prostate Cancer, with Mark L. Gonzalgo, MD, PhD

      Amy M. Pearlman, MD
      Study to assess combination of MRI and PSMA-PET for prostate cancer detection
      September 23rd 2025

      Study to assess combination of MRI and PSMA-PET for prostate cancer detection

      Hannah Clarke
      Pearls & Perspectives: Prostate MRI and Focal Therapy, with Dan Sperling, MD, DABR
      September 23rd 2025

      Pearls & Perspectives: Prostate MRI and Focal Therapy, with Dan Sperling, MD, DABR

      Amy M. Pearlman, MD
      FDA greenlights phase 1 trial of alpha radioligand therapy in mCRPC
      September 23rd 2025

      FDA greenlights phase 1 trial of alpha radioligand therapy in mCRPC

      Hannah Clarke
      Key takeaways from the COMRADE trial in CRPC, with Rana McKay, MD
      September 23rd 2025

      Key takeaways from the COMRADE trial in CRPC, with Rana McKay, MD

      Rana R. McKay, MD
      © 2025 MJH Life Sciences

      All rights reserved.